We pretreated RA neutrophils with classical NET inhibitors,21 including DPI (a NADPH oxidase inhibitor), Cl-amidine (a PAD4 inhibitor), or Sivelestat (an NE inhibitor), prior to stimulation with IL-33. Here, FMO5 is linked to rheumatoid arthritis.